Explore
Validate
Learn
Western blot
Blocking/NeutralizingAntibody data
- Antibody Data
- Antigen structure
- References [2]
- Comments [0]
- Validations
- Blocking/Neutralizing [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- MAB525 - Provider product page
- Provider
- R&D Systems
- Product name
- Rat CXCL2/GRO beta/MIP-2/CINC-3 Antibody
- Antibody type
- Monoclonal
- Description
- Protein A or G purified from hybridoma culture supernatant. Detects rat CXCL2/GRO beta/MIP-2/CINC-3 in ELISAs and Western blots. In sandwich ELISAs, less than 0.5% cross-reactivity with recombinant rat (rr) CXCL3 and less than 0.1% cross-reactivity with rrCXCL1, rrCINC-2 alpha , recombinant mouse (rm) CXCL9 or rmCXCL2 is observed. In Western blots, less than 3% cross-reactivity with recombinant human (rh) CXCL8, recombinant porcine CXCL8, or rrCINC-2 alpha and no cross-reactivity with rrCXCL1, 3, rmCXCL1, 2, 6, 9, 10, 12, rhCXLC1, 2, 3, 5, 6, 7, 9,10, 11, 12 or 13 is observed.
- Reactivity
- Rat
- Host
- Mouse
- Conjugate
- Unconjugated
- Antigen sequence
P30348- Isotype
- IgG
- Antibody clone number
- 123802
- Vial size
- 500 ug
- Storage
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Submitted references Rat coronaviruses infect rat alveolar type I epithelial cells and induce expression of CXC chemokines.
Cardiac inflammation contributes to right ventricular dysfunction following experimental pulmonary embolism in rats.
Miura TA, Wang J, Holmes KV, Mason RJ
Virology 2007 Dec 20;369(2):288-98
Virology 2007 Dec 20;369(2):288-98
Cardiac inflammation contributes to right ventricular dysfunction following experimental pulmonary embolism in rats.
Watts JA, Zagorski J, Gellar MA, Stevinson BG, Kline JA
Journal of molecular and cellular cardiology 2006 Aug;41(2):296-307
Journal of molecular and cellular cardiology 2006 Aug;41(2):296-307
No comments: Submit comment
Supportive validation
- Submitted by
- R&D Systems (provider)
- Main image
- Experimental details
- Chemotaxis Induced by CXCL2/CINC-3 and Neutral-ization by Rat CXCL2/ CINC-3 Antibody. Recombinant Rat CXCL2/CINC-3 (Catalog # 525-C3) chemoattracts the BaF3 mouse pro-B cell line transfected with human CXCR2 in a dose-dependent manner (orange line). The amount of cells that migrated through to the lower chemotaxis chamber was measured by Resazurin (Catalog # AR002). Chemotaxis elicited by Recombinant Rat CXCL2/ CINC-3 (0.1 µg/mL) is neutral-ized (green line) by increasing concentrations of Mouse Anti-Rat CXCL2/CINC-3 Monoclonal Antibody (Catalog # MAB525). The ND50 is typically 0.4-2.0 µg/mL.
